Actelion: Opsumit demonstrates best-in-class profile for newly diagnosed patients

BUY, Fair Value CHF73 (+5%)

News published on October Tuesday 29, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities